Treatment Education for Perinatal Women and Their Community Support
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: substance abuse treatment education.
- Who it may be relevant to
- Registry conditions: Opioid Dependency. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Treatment Education for Pre- and Postpartum Women and Their Community Support
Overview
The study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women with opioid use disorder and a community support person. The education session provides correct information about opioid agonist medications and neonatal abstinence syndrome.
Detailed description
Perinatal women with opioid disorder often face criticism by social network members for receiving opioid agonist treatment. Feeling stigmatized by others may impact willingness to start and remain in agonist treatment.
The present study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women who are treated using an agonist medication (methadone or buprenorphine) and community support chosen by the patient.
Study participants will be recruited from perinatal women who receive substance abuse treatment at the Center for Addiction and Pregnancy or Addiction Treatment Services at Johns Hopkins Bayview campus. These women will work with a counselor to select a community support person to bring to the program for the education session.
The session will provide correct information on opioid agonist medications and neonatal abstinence syndrome. This session will follow a structured outline.
Interventions
- Other substance abuse treatment education
Perinatal women and the women's community support will receive a 50 minute education session that provides correct information on opioid agonist medications and neonatal abstinence syndrome.
Primary outcome measures
- Percentage of women interested in study participation [Time frame: Immediately before session 1]
- Percentage of interested women who bring in community support to the education group [Time frame: Immediately before session 1]
Secondary outcome measures (1)
- Knowledge as assessed by survey [Time frame: Baseline, Immediately after session 1]
Eligibility criteria
Inclusion criteria
- perinatal women treated with agonist medication
- interest in study participation
- interest in community support:
- interest in study participation
Exclusion criteria
- perinatal women not treated with agonist medication
- not interested in study participation
- not interested in community support:
- not interested in study participation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06733649 · IRB00478467